切换导航
About Us
Our Story
Our Mission
History
Global Footprint
Leadership
Board of Directors
Science & Technology
Pipeline
Collaborations
CDMO Services
About CDMO
Strength
Services Offered
Learn More
Investors & Media
Join Us
EN
中文
Home
>
Pipeline
Pipeline
Diverse Pipeline
Integrated, scalable, proprietary manufacturing platform
Unique mechanisms of action
Small production footprint to produce billions of doses of vaccines
Rapidly adapted to address new variants of concern
Long shelf life at 2- 8 °C
Pipeline
Target/MoA
Discovery
Pre-Clinical
Phase 1/2
Phase 3
Commercial
Oncology
JCXH-211
( srRNA )
IL-12
JCXH-211
( srRNA )
IL-12
Cancer Vaccines
JCXH-212
( srRNA )
Cancer Vaccine
JCXH-212
( srRNA )
Cancer Vaccine
Cytokines
Infectious Diseases
JCXH-221
(mRNA)
Vaccine
JCXH-221
(mRNA)
Vaccine
Broadly protective COVID
JCXH-105
( srRNA )
Vaccine
JCXH-105
( srRNA )
Vaccine
Shingles
JCXH-107
( mRNA )
Vaccine
JCXH-107
( mRNA )
Vaccine
Seasonal quadri/trivalent influenza
JCXH-108
(mRNA)
Vaccine
JCXH-108
(mRNA)
Vaccine
RSV
TBD
( mRNA )
Vaccine
TBD
( mRNA )
Vaccine
Flu/COVID combo
TBD
( srRNA )
Vaccine
TBD
( srRNA )
Vaccine
HSV-2
Rare Diseases
JCXH-301
( mRNA )
Enzyme Replacement
JCXH-301
( mRNA )
Enzyme Replacement
Gaucher’s Disease
Medical Cosmetology
JCXH-G
( mRNA)
Undisclosed
JCXH-G
( mRNA)
Undisclosed
Therapeutic acnes vaccine